Elahere 100 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DX25FVFRN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $17,244
Award facts
- Contract value 100% obligated
- $17,243.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of ELAHERE (mirvetuximab soravtansine) 100 mg/20 mL vials, with a ceiling value of $17,243.76 and a completion date of June 24, 2025. This firm fixed-price, non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The supply will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations.
ELAHERE is a specialty oncology medication indicated for certain ovarian cancer treatments, reflecting the critical role AmerisourceBergen plays in supplying specialized pharmaceutical products to support military healthcare systems. As a major pharmaceutical distributor and the incumbent prime vendor under the DLA's global pharmaceutical support program, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. The company's extensive federal contract portfolio demonstrates its capability to manage complex medical supply chains and fulfill delivery orders across a broad spectrum of therapeutic domains, from specialty medications to generic pharmaceuticals and medical devices, all on a competitive, firm fixed-price basis.
Quick answers
Who was awarded contract SPE2DX25FVFRN?
SPE2DX25FVFRN was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on June 2, 2025.
How much is contract SPE2DX25FVFRN worth?
The government has obligated $17,244 on SPE2DX25FVFRN.
Is contract SPE2DX25FVFRN an order under another contract?
Yes. SPE2DX25FVFRN is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVFRN competed?
The extent of competition for SPE2DX25FVFRN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award